Novel butyrylcholinesterase inhibitors through pharmacophore modeling, virtual screening and DFT-based approaches along-with design of bioisosterism-based analogues

详细信息    查看全文

• 作者：Dhrubajyoti Gogoi^a ; Amrita Kashyap Chaliha^b ; Diganta Sarma^c ; Bibhuti Bhusan Kakoti^a ; Alak Kumar Buragohain^b ; ^{alakkrburagohain@gmail.com} ; ^{alak@dibru.ac.in}
• 关键词：Butyrylcholinesterase (BChE) ; Pharmacophore modeling ; Molecular docking ; ADMET ; DFT
• 刊名：Biomedicine & Pharmacotherapy
• 出版年：2017
• 出版时间：January 2017
• 年：2017
• 卷：85
• 期：Complete
• 页码：646-657
• 全文大小：2979 K
• 卷排序：85

文摘

Ligand and structure-based pharmacophore models were used to identify the important chemical features of butyrylcholinesterase (BChE) inhibitors. A training set of 16 known structurally diverse compounds with a wide range of inhibitory activity against BChE was used to develop a quantitative ligand-based pharmacophore (Hypo1) model to identify novel BChE inhibitors in virtual screening databases. A structure-based pharmacophore hypothesis (Phar1) was also developed with the ligand-binding site of BChE in consideration. Further, the models were validated using test set, Fisher’s Randomization and Leave-one-out validation methods. Well-validated pharmacophore hypotheses were further used as 3D queries in virtual screening and 430 compounds were finally selected for molecular docking analysis. Subsequently, ADMET, DFT and chemical similarity search were employed to narrow down on seven compounds as potential drug candidates. Analogues of the best hit were further developed through a bioisosterism-guided approach to further generate a library of potential BChE inhibitors.